Sei Investments Co. Trims Position in Cencora, Inc. $COR

Sei Investments Co. decreased its holdings in shares of Cencora, Inc. (NYSE:COR) by 0.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 504,571 shares of the company’s stock after selling 2,302 shares during the period. Sei Investments Co. owned approximately 0.26% of Cencora worth $158,505,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Kemnay Advisory Services Inc. purchased a new stake in Cencora during the 4th quarter valued at approximately $25,000. Oakworth Capital Inc. acquired a new stake in Cencora during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC purchased a new position in shares of Cencora in the 4th quarter valued at approximately $27,000. Archer Investment Corp grew its stake in shares of Cencora by 134.3% in the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. Finally, Motiv8 Investments LLC acquired a new position in shares of Cencora in the fourth quarter valued at approximately $29,000. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on COR shares. Morgan Stanley set a $342.00 price target on Cencora in a research note on Friday, May 8th. Weiss Ratings cut shares of Cencora from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 30th. Evercore set a $360.00 price objective on shares of Cencora in a research note on Wednesday, April 8th. Bank of America upped their price objective on shares of Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Finally, UBS Group raised their target price on shares of Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $367.75.

Cencora Stock Performance

Shares of COR stock opened at $304.57 on Friday. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The stock has a 50 day simple moving average of $283.47 and a 200-day simple moving average of $316.51. The company has a market cap of $59.26 billion, a price-to-earnings ratio of 23.36, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54.

Cencora (NYSE:COR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter last year, the firm earned $4.42 earnings per share. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities analysts forecast that Cencora, Inc. will post 17.79 EPS for the current year.

Cencora Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. Cencora’s dividend payout ratio is 18.40%.

Cencora announced that its board has authorized a share repurchase program on Thursday, May 21st that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.

Insider Activity

In related news, Director Lauren M. Tyler acquired 550 shares of Cencora stock in a transaction that occurred on Monday, June 22nd. The stock was purchased at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the purchase, the director directly owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.38% of the stock is owned by corporate insiders.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.